News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Antonio D’Alessio: RACB Study conversion therapy with AtezoBev in initially unresectable HCC
Antonio D'Alessio/X
Jan 26, 2025, 08:04

Antonio D’Alessio: RACB Study conversion therapy with AtezoBev in initially unresectable HCC

Antonio D’Alessio, Medical Oncologist and PhD student at Imperial College London, posted on X:

“RACB Study: interesting trial design of conversion therapy with AtezoBev in initially unresectable HCC.
However:

  • PR 13%, but resection rate 48%
  • Any grade AEs 66%
  • No standardized definition of unresectable HCC.”

Antonio D'Alessio: RACB Study conversion therapy with AtezoBev in initially unresectable HCC

Antonio D'Alessio cancer HCC OncoDaily Oncology RACB Study
Special Coverage
Societies
Mar 6, 2025, 13:51
15 Posts Not To Miss From BTOG 2025
Blog
Mar 6, 2025, 13:02
Cancer Care in Conflict Zones: The Silent Struggle - Institute of Cancer and Crisis
Blog
Mar 6, 2025, 12:54
Zainab Shinkafi-Bagudu: HPV is a silent but significant threat
Blog
Mar 6, 2025, 12:43
Colorectal cancer incidences are on the rise among younger populations - NFCR
Oncolibrary
Mar 6, 2025, 12:41
Daiichi Sankyo's and Astrazeneca's press release on ENHERTU®: Latest Updates from DESTINY-Gastric04 trial
Blog
Mar 6, 2025, 12:37
Norman Ng: Do you gain or lose when you are diagnosed with cancer?
Drugs
Mar 6, 2025, 12:21
Zolbetuximab: Uses in Cancer, Side Effects, Dosages, Expectations, and More
Blog
Mar 6, 2025, 12:16
Stephen V Liu: Houda Bahig on the role of radiation in the era of perioperative immunotherapy for NSCLC
Science
Mar 6, 2025, 10:57
Armando Orlandi: NA-PHER2 study shows HER2+/ER+ breast cancers can be treated without chemotherapy
Science
Mar 6, 2025, 10:44
Adam B. Weiner: SBRT and ADT for oligometastatic prostate cancer
Blog
Mar 6, 2025, 10:40
ISLB Global Survey: Oncologist Attitudes and Practices on Liquid Biopsy
Science
Mar 6, 2025, 10:30
Myeloma Paper of the Day, March 6th, suggested by Robert Orlowski